Up a level |
Anpalakhan, Shobana, Huddar, Prerana, Behrouzi, Roya, Signori, Alessio, Cave, Judith, Comins, Charles, Cortellini, Alessio, Addeo, Alfredo, Escriu, Carles ORCID: 0000-0003-3638-3202, McKenzie, Hayley et al (show 7 more authors)
(2023)
The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24 (2).
1746-.
Banna, Giuseppe L, Cantale, Ornella, Muthuramalingam, Sethupathi, Cave, Judith, Comins, Charles, Cortellini, Alessio, Addeo, Alfredo, Signori, Alessio, McKenzie, Hayley, Escriu, Carles ORCID: 0000-0003-3638-3202 et al (show 7 more authors)
(2022)
Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: The Spinnaker retrospective study.
INTERNATIONAL IMMUNOPHARMACOLOGY, 110.
108985-.
Anpalakhan, Shobana, Huddar, Prerana, Behrouzi, Roya, Signori, Alessio, Cave, Judith, Comins, Charles, Cortellini, Alessio, Addeo, Alfredo, Escriu, Carles ORCID: 0000-0003-3638-3202, McKenzie, Hayley et al (show 9 more authors)
(2023)
Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis.
FRONTIERS IN ONCOLOGY, 13.
1163768-.
Lindsay, Colin R, Shaw, Emily C, Moore, David A, Rassl, Doris, Jamal-Hanjani, Mariam, Steele, Nicola, Naheed, Salma, Dick, Craig, Taylor, Fiona, Adderley, Helen et al (show 17 more authors)
(2021)
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists.
BRITISH JOURNAL OF CANCER, 125 (9).
pp. 1210-1216.
Arriola, Edurne, Wheater, Matthew, Galea, Ian, Cross, Nadia, Maishman, Tom, Hamid, Debbie, Stanton, Louise, Cave, Judith, Geldart, Tom, Mulatero, Clive et al (show 6 more authors)
(2016)
Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC.
JOURNAL OF THORACIC ONCOLOGY, 11 (9).
pp. 1511-1521.
Naheed, Salma, Holden, Chloe, Tanno, Lulu, Pattini, Linda, Pearce, Neil W, Green, Bryan, Jaynes, Eleanor, Cave, Judith, Ottensmeier, Christian H ORCID: 0000-0003-3619-1657 and Pelosi, Giuseppe
(2022)
Utility of KI-67 as a prognostic biomarker in pulmonary neuroendocrine neoplasms: a systematic review and meta-analysis.
BMJ OPEN, 12 (3).
e041961-.
Naheed, Salma, Holden, Chloe, Tanno, Lulu, Jaynes, Eleanor, Cave, Judith, Ottensmeier, Christian H ORCID: 0000-0003-3619-1657 and Pelosi, Giuseppe
(2019)
The utility of Ki-67 as a prognostic biomarker in pulmonary neuroendocrine tumours: protocol for a systematic review and meta-analysis.
BMJ OPEN, 9 (8).
e031531-.